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Early apoptosis real-time detection by label-free
SERS based on externalized phosphatidylserine†
Haibo Zhou,‡a Qiqin Wang,‡a Detian Yuan,‡a,b Jinyong Wang,c Yang Huang,a
Huihui Wu,a Jingyi Jian,a Danting Yang,d Ning Huang,b Christoph Haisch,e
Zhengjin Jiang*a and Shanze Chen*b,f
Apoptosis is a tightly regulated cellular process that plays an essential role in the development, aging,
cancer biology, immune response, and pathogenesis of various diseases. Herein, we report a new SERS
sensing strategy for in vitro sensitive detection of early apoptotic cells. The principle of this method is to
in situ synthesize silver nanoparticles (AgNPs) on the phosphatidylserine (PS) of the apoptotic cell mem-
brane during the early apoptosis, which enables distinguishing normal and apoptotic cells. The total assay
time of the presented method is only 10 min, thus being faster, cheaper and simpler than current tech-
niques for the detection of apoptosis. The intrinsic mechanism was veriﬁed by diﬀerent approaches based
on externalized phosphatidylserine. In addition, the detection process is real-time and label-free; i.e., the
intrinsic SERS spectra from the cellular membrane are directly employed for apoptosis real-time detec-
tion, which avoids using additional chemical or biological reagents as external signal indicators. Therefore,
our SERS approach may serve as a potentially practical tool for sensitive and real-time detection of early
cell apoptosis, complementing the state-of-the-art strategies, e.g. ﬂow cytometry. While further investi-
gation is required to better understand the intrinsic mechanism of the in situ coating method, the current
results may provide another choice for real-time detection of early apoptosis.
Introduction
In a multicellular organism or tissue, cells that are no longer
needed or are damaged are recognized to be a threat to the
organism, and thus it is necessary to destroy and remove these
cells by a tightly regulated cell suicide process known as pro-
grammed cell death, also called apoptosis.1,2 Apoptosis can be
triggered by a variety of stresses, such as heat, radiation, nutri-
ent deprivation, viral infection, hypoxia, exposure to toxic sub-
stances and increased intracellular calcium concentration.3
Apoptosis is initiated by the activation of a complex process
composed of multiple intracellular and extracellular events,
such as caspase activation, release of cytochrome c (Cyt c)
from mitochondria, externalization of phosphatidylserine on
the membrane and DNA fragmentation.4 Apoptosis is charac-
terized by specific morphological changes such as membrane
blebbing, cell shrinkage and nuclear fragmentation.5–7 Apop-
tosis plays a crucial role in embryonic development and in
balancing proliferation and death rate in tissue.8 Additionally,
it has been proven that many diseases such as degenerative
disorders (excessive apoptosis), autoimmune disorders and
cancers (inadequate apoptosis) result from deregulation of
apoptosis.9,10 Due to the importance of this complex process
in cell biology, development of technologies to monitor the
progression of apoptosis and detect the apoptotic signaling
will benefit humankind on the aspect of disease treatment
and diagnosis.
Currently, transmission electron microscopy and time-lapse
microscopy are widely used to analyze the morphologic
changes of apoptotic cells versus normal cells.11 A number of
molecular biological techniques aim at the analysis of land-
mark events during apoptosis, for example, western blotting
for caspase activation.12 Another commonly used detection
†Electronic supplementary information (ESI) available: Experimental details and
additional figures. See DOI: 10.1039/c6an00606j
‡These authors contributed equally to this work.
aDepartment of Pharmacy and Guangdong Province Key Laboratory of
Pharmacodynamic of Traditional Chinese Medicine & New Drug Research,
Jinan University, Guangzhou, Guangdong Province 510632, China.
E-mail: jzjjackson@hotmail.com
bDepartment of Pathophysiology, West China School of Preclinical Sciences and
Forensic Medicine, Sichuan University, Chengdu, Sichuan Province 610041, China.
E-mail: chenshanze2007@sina.com
cCollege of Veterinary Medicine, Huazhong Agricultural University, Wuhan, 430070,
China
dSchools of Biosystems Engineering and Food Science, Zhejiang University,
866 Yuhangtang Road, Hangzhou, Zhejiang Province 310058, China
eChair for Analytical Chemistry, Technische Universität München, Marchioninistr.
17, D-81377 Munich, Germany
fComprehensive Pneumology Center (CPC), Institute of Lung Biology and Disease,
Helmholtz Zentrum München, Neuherberg, Germany














































View Journal  | View Issue
method relies on a fluorescent labeled antibody, which
includes the imaging of caspase activation in apoptotic cells
by fluorescent microscopy.13 Recent eﬀorts have focused on
the design of activity-based probes (ABPs) to enzymes such as
caspase-3.14 Vickers et al. generated fluorescent and biotiny-
lated probes capable of selective detection of caspase-3 using
key unnatural amino acids. Moreover, it has been reported that
nanomaterials can be applied for apoptosis detection.15 Chen
et al. have developed a novel fluorescence activation nanosen-
sor for the imaging of cytosolic Cyt c released from mitochon-
dria in apoptotic cells.16 Besides the cytosolic molecules, the
changes in the cell membrane can also be utilized as an indi-
cator for apoptosis. It is worthy of note that externalization of
phosphatidylserine (PS) on plasma membrane is an early event
during apoptosis, which provides an “eat me” signal to phago-
cyte.17 Phosphatidylserine, an important phospholipid mem-
brane component, binds specifically to a fluorescent dye,
conjugated annexin-V with the exposed charged head groups,
in a Ca2+ dependent process, thus allowing us to analyze the
apoptosis by flow cytometry or fluorescent microscopy.18,19
However, all of the abovementioned methods require fixation
and permeabilization, hampering dynamic monitoring of the
apoptotic process. Furthermore, the introduction of fluo-
rescent dyes into cells during measurements may damage the
cells and interfere with the apoptotic machinery. Therefore,
there is still a strong need to develop novel strategies for
simple, rapid, and if possible fluorescent dye free (called label-
free) dynamic monitoring and detection of apoptotic cells.
Since the discovery of a significant enhancement of Raman
signals at the rough silver electrode surface,20–22 surface-
enhanced Raman scattering (SERS) has gained increasing
attention as a powerful analytical tool for the detection of bio-
logical species,23–26 for molecular imaging,27 and for monitor-
ing microorganisms,28–30 cells31,32 and tissues,33 even in vivo.34
In comparison with normal Raman signals, SERS signals may
be enhanced by a factor of up to 106–1014, when the target
molecules are located on the nanoparticle aggregates or at the
nanostructural junctions (“hot spots”).35,36 This huge enhance-
ment enables SERS to serve as an ultrasensitive detection tool
in various analytical areas. Besides the sensitivity, its intrinsic
selectivity based on the spectroscopic fingerprint, its simple
and fast realization, and its nondestructive nature in aqueous
environment make SERS an ideal tool for label-free, in situ and
real-time analyses of biological samples.37
Over the past decade, a series of SERS-active substrates have
been developed for bio-sensing applications such as ultra-
sensitive detection of cell division and diﬀerentiation via
detecting signals from various biomolecules (e.g., DNA, RNA,
proteins and glycan).38,39 A recent report revealed that SERS
performed with specific nanomaterials (AgNPs@Si) is able to
detect cell apoptosis at the single-cell level based on the
decreased SERS intensity of cells.40 However, they did not
discuss in detail the underlying mechanism by which the
SERS signal intensity of apoptotic cells decreased. Moreover,
we have previously reported a fast and easy method to grow
AgNPs on the surface of Gram-negative bacteria (E. coli), which
allows the label-free in situ discrimination of live and dead bac-
teria.29 Therefore, we speculated whether our method could
also be applied to the detection of the mammalian cell status.
Particularly, we were interested in apoptotic cell detection
owing to the important role of apoptosis in many healthy and
disease conditions.
Herein, we have developed a new and label-free SERS strat-
egy for apoptosis detection, using the in situ coating method,
i.e., silver nanoparticle coating on the apoptotic cell mem-
brane, as an active, eﬃcient and reproducible SERS apoptotic
platform. Once apoptosis is induced by drugs, the outside
layer of the apoptotic cell membrane becomes negatively
charged due to the externalized phosphatidylserine. We first
soaked the apoptotic cell in a silver nitrate (AgNO3) solution
and then used hydroxylamine hydrochloride (NH2OH·HCl) as
a reducing agent. Eventually, a “colloid deposit” was formed
on the apoptotic cell membrane. As a result, cells at diﬀerent
apoptotic stages were readily analyzed via recording the SERS
intensity of the cell membrane components distributed on the
cell membrane. Our results suggest new possibilities for
finding novel SERS-based in vitro biomedical applications, as
well as provide a powerful strategy for dynamic and sensitive
apoptosis detection.
Results and discussion
Scheme 1 illustrates the in situ formation of AgNPs coating on
the apoptotic cell membrane. When the AgNO3 solution is
added to the normal cell suspension, silver ions (Ag+) cannot
adsorb onto the membrane of normal cells, due to a lack of
interaction between Ag+ and phosphatidylserine. However, Ag+
strongly adheres to the externalized phosphatidylserine of the
apoptotic cell membrane by the electrostatic interaction
between the positively charged Ag+ and the negatively charged
–COO− and –NH2 on the externalized phosphatidylserine.
Finally, the addition of the reducing agent (hydroxylamine
hydrochloride, NH2OH·HCl) led to the formation of colloid
deposits only on the surface of apoptotic cells. For the normal
Scheme 1 Schema of the detection mechanism of apoptosis based on
in situ synthesis of nanoparticles on the apoptotic cell membrane. The
Ag+ adsorbed onto the apoptotic cell membrane by electrostatic attrac-
tion generates AgNPs on the membrane immediately after the addition
of the reducing reagent.
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cells, the AgNPs are just randomly formed in the suspension
and do not attach onto the normal cell membrane.
Staurosporine, a natural product originally isolated from
the bacterium Streptomyces staurosporeus,14 has been used as a
standard chemical to induce cell apoptosis.15 In this work, we
used this chemical to induce apoptosis of HL-60 cells. To
investigate whether SERS can be used to diﬀerentiate normal
cells and apoptotic cells, 1 × 106 cells per mL HL-60 cells, both
normal and apoptotic ones, were prepared by this in situ
coating method (the detailed procedure is described in the
Experimental Section of the ESI†) as samples for SERS detec-
tion. As shown in Fig. 1, almost no SERS signals were detected
in the normal cells, whereas the SERS signals were highly
strong in the apoptotic cells. The typical SERS peaks at 665,
726, 1332, and 1576 cm−1 were observed, which might be
attributed to the cellular lipids, proteins, and carbo-
hydrates40,41 (see the tentative assignments of peaks in
Table S1 of the ESI†). In addition, as shown in the insert
picture of Fig. 1, a transparent suspension was observed in the
normal cells after in situ coating preparation, whereas the
color of the apoptotic cell suspension became bluish-green
gradually, indicating that the AgNPs were formed in the apop-
totic cell suspension but not in the normal cell group. These
results were similar to our study reported previously.29
Apoptosis can be seen as a multi-step process, which can
be separated into induction to early, intermediate and late-
stages.42 It is important to develop methods and reagents to
distinguish the various apoptotic stages, in particular for the
detection of early apoptosis with the intact membranes. In
order to further determine whether our SERS method is able
to detect in a stage dependent manner the apoptotic process,
HL-60 cells at 3 h, 5 h and 7 h after induction of apoptosis
were prepared with the in situ coating method described above
and SERS was performed. As shown in Fig. 2, we observed that
the intensity of the SERS signals significantly increased with
time. A calibration curve derived from multiple independent
experiments, i.e., from the analysis of diﬀerent cultivations,
measured from diﬀerent production batches (each data point
representing an average of at least three independent measure-
ments), can be found in Fig. 2B. These results indicate that
the sensitivity of our method is high as we can diﬀerentiate
the cell apoptosis with a 2 h interval. Moreover, these results
demonstrate that our method is capable of detecting early cell
apoptosis, which cannot yet be recognized based on changes
in morphology.
The early stage of apoptosis is characterized by the loss of
mitochondrial membrane potential and the release of cytosolic
Cyt c accumulations from the mitochondria.43 Fujita et al.
developed a label-free method to observe Cyt c dynamics
during apoptosis by SERS, based on its unique structure.44
Another key apoptotic process is the translocation of PS, a
phospholipid that transmits from the cytosolic (inner) side of
the cell membrane to the extracellular (outer) surface in the
early/middle apoptosis. The externalization of PS increases
with the apoptotic process. Many methods have been develo-
ped for the analysis of early apoptosis based on these mole-
cular events. Due to the specific binding ability to PS, annexin-
V staining, paired with fluorochrome (e.g. propidium iodide,
PI), is widely used to identify early cell apoptosis by flow cyto-
metry.45 To compare our SERS approach with flow cytometry,
samples at the same time stage of apoptosis of HL-60 cells
after treatment with staurosporine were analyzed by flow cyto-
metry with the annexin-V/PI protocol. As shown in Fig. 3, the
percentages of apoptotic HL-60 cells at 0 h, 3 h, 5 h and 7 h
are 4.9%, 13.9%, 46.1% and 52.3%, respectively. These results
indicate that our approach has the similarly sensitivity as flow
cytometry, which is commonly used to detect time stages of
apoptosis. Notably, the SERS technique is much faster,
simpler and lower-cost than flow cytometry. Thus, it has a
potential to replace the time-consuming, laborious, sophisti-
cated and expensive flow cytometry technique in the future.
For a more precise explanation of the distinct SERS signal
source for normal and apoptosis cells by the in situ coating
method, bright-field microscopy was performed to investigate
the morphology of the cells and the distribution of AgNPs.
Fig. 4A and B depict the bright-field images of normal cells
Fig. 1 SERS spectra of normal and apoptosis cells obtained by the
in situ coating method. The inset picture shows the corresponding color
of the suspension.
Fig. 2 (A) SERS spectra of apoptotic cells with diﬀerent times (0 h, 3 h,
5 h and 7 h). (B) The corresponding Raman intensity at 665 cm−1 vs. time
after apoptosis. The error bars represent three independent experiments
for each sample.
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and apoptotic cells, respectively. In contrast to normal cells
that were intact and circled, apoptotic cells showed shrinkage,
nuclear fragmentation, and chromatin condensation, which
confirm that these cells were in the process of apoptosis.
When normal cells were prepared using the in situ coating
method (Fig. 4C), the AgNPs (black dots) were randomly dis-
tributed in the suspension and did not aggregate on the
surface of the normal cells. Some of them were self-aggregated
in the suspension, but they did not adhere to the cellular
membrane, which mostly remains uncoated, and these cells
remain mostly separated. Consequently, the Raman signals of
the cell membrane components cannot be eﬃciently amplified
by electromagnetic field enhancement, resulting in very weak
SERS signals. Fig. 4D reveals the intimate contact of AgNPs
with the apoptotic cellular membrane. Most of the AgNPs
coated the cellular membrane, whereas only a few were found
unbound or clustered in the liquid phase. The shape of the
AgNPs was irregular. Some of the composites representing
large structures (indicated by red arrows in Fig. 4D) were likely
to aggregate spontaneously, forming AgNP clusters on the
surface of apoptotic cells. Moreover, most of the apoptotic
cells were coated by aggregated AgNPs and were assembled in
clusters under these conditions, which form highly SERS-
active hot spots on the interfaces of apoptotic cells and, conse-
quently, strong Raman signals were detected. The growth of
AgNPs on the apoptotic cell surface was consistent with the
finding of our previously reported paper that AgNPs accumu-
late on the bacterial surface.28,29
Rayleigh scattering is a powerful tool to real-time visualize
metal nanoparticles in solution.46 Hence, we used dark field
microscopy to further investigate the dynamic synthesis of
AgNPs on the apoptotic cell membrane by directly monitoring
this process. After the preparation using the in situ coating
method, 50 μL of samples were dropped on the micro glass
slide for real-time monitoring of the synthesis of AgNPs. We
observed that AgNPs displayed random Brownian motion and
the single AgNP and corresponding aggregates were visualized
as blue and orange scattering structures in the blank solution
(Fig. 5A). Furthermore, we can clearly see that the AgNPs were
synthesized on the apoptotic cell membrane (indicated by red
arrows in Fig. 5C), whereas there were almost no AgNPs on the
normal cell membrane. To verify that the adhered AgNPs on
the apoptotic cell membrane were not from the solution, we
moved the objective focal plane from the top of the cell to the
bottom. As shown in Fig. 5B and C, AgNPs were always
observed (or found), at diﬀerent focal planes, sitting on the
surface (or membrane) of the apoptotic cell but not on the
Fig. 3 Detection of apoptosis cells at diﬀerent time points (0 h, 3 h, 5 h
and 7 h) by ﬂow cytometry. Cells were stained with annexin-V/PI. All the
other parameters were consistent with Fig. 2.
Fig. 4 Bright-ﬁeld images of normal cells (A) and apoptotic cells (B)
and the corresponding bright-ﬁeld images of normal cells (C) and apop-
totic cells (D) treated with the in situ coating method. The red arrows in
(D) show the aggregated AgNPs on the cellular membrane.
Fig. 5 Rayleigh scattering images of blank (A), normal cells (B) and
apoptotic cells (C) treated with the in situ coating method. From left to
right, the images were photographed from the same cells from top to
bottom. The red arrows show the AgNP coating on the cellular
membrane.
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normal cell membrane. In addition, we observed that the
AgNPs on the membrane of apoptotic cells displayed confined
diﬀusions compared with those in blank solution, which
further confirmed that the AgNPs were synthesized in situ on
the apoptotic cell membrane using our novel coating method
(see ESI Video SI†).
As shown above, we had used annexin-V/PI for the analysis
of early cell apoptosis using a Fluorescence Activated Cell
Sorter (FACS), annexin-V is a Ca2+-dependent phospholipid-
binding protein with high aﬃnity to PS, and binds to exposed
PS on the surface of apoptotic cells. Due to the similarity of
Ag+ and Ca2+, we speculated whether our in situ coating strat-
egy shares a mechanism similar to annexin-V based FACS
analysis. In order to verify that the main mechanism of our
in situ coating strategy is dependent on the binding of Ag+ to
the negatively charged apoptotic cell membrane, we used a
certain concentration of Ca2+ (final concentration is 4.8 × 10−4 M)
and PS (final concentration is 5 × 10−5 M). First, we added
Ca(NO3)2 as the original source of Ca
2+ to the suspension of
apoptotic cells, followed by the in situ coating method. We
observed that the SERS signals dramatically decreased upon
adding Ca(NO3)2, to a level almost equal to normal cells
(Fig. 6A). This was due to the first binding of Ca2+ with the cel-
lular membrane through electrostatic interaction, thus block-
ing the adhering of Ag+ to the cellular membrane through the
same electrostatic attraction. Furthermore, Ca2+ has stronger
electrostatic interaction with the cellular membrane than Ag+
due to its higher positive charge. Thus the AgNPs could not be
synthesized on the surface of apoptotic cells. Consequently,
very weak SERS signals were observed. Meanwhile, when we
added phosphatidylserine (PS) to the cell suspension before
the in situ coating sample preparation, no significant SERS
signal was detected, indicative of binding competition of Ag+
between the PS in the solution and the PS on the cellular
membrane. Inadequate Ag+ were synthesized to AgNPs on the
PS of apoptotic cells. Consequently, very weak SERS signals
were obtained, as shown in Fig. 6B. Moreover, we observed
that there was no detection of SERS signals in pure PS with
our in situ coating method, further indicating that the SERS
signals came from other cell membrane components than PS,
such as protein, carbohydrate and cholesterol.
Conclusions
We report a new SERS in vitro sensing strategy for the sensitive
detection of early cell apoptosis. This strategy is based on a
fast and easy method to in situ synthesize AgNPs on the PS of
the apoptotic cell membrane during early apoptosis. The total
assay time of the presented method is only 10 min. Remark-
ably, the intrinsic mechanism was verified by diﬀerent
approaches. In addition, the detection process is label-free; the
cellular membrane intrinsic SERS spectra are directly
employed for apoptosis detection, which is free of additional
chemical or biological reagents as external signal indicators.
Therefore, our SERS approach may serve as a potentially practi-
cal tool for the sensitive, precise and real-time detection of
apoptotic cells, complementing the state-of-the-art strategies
for apoptosis detection. Further investigations will be devoted
to further understanding the mechanism of the in situ coating
method, and to test it with other agents inducing apoptosis.
The current results may provide another choice for early
apoptosis real-time detection.
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